Oaktree Acquisition Corp. III Life Sciences (OACC)

Nasdaq: OACC · CIK 0002029769 · United States

Every official Oaktree Acquisition Corp. III Life Sciences filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Open OACC filings

Oaktree Acquisition Corp. III Life Sciences documents

Oaktree Acquisition Corp. III Life Sciences 10-K 2026OACC 10-K 2026: annual report for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences 10-K 2025OACC 10-K 2025: annual report for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences 10-K 2024OACC 10-K 2024: annual report for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences 10-K 2023OACC 10-K 2023: annual report for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences 10-K 2022OACC 10-K 2022: annual report for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences 10-Q 2026OACC 10-Q 2026: quarterly report for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences 10-Q 2025OACC 10-Q 2025: quarterly report for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences 10-Q 2024OACC 10-Q 2024: quarterly report for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences 10-Q 2023OACC 10-Q 2023: quarterly report for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences 10-Q 2022OACC 10-Q 2022: quarterly report for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences 8-K 2026OACC 8-K 2026: current report for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences 8-K 2025OACC 8-K 2025: current report for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences 8-K 2024OACC 8-K 2024: current report for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences 8-K 2023OACC 8-K 2023: current report for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences 8-K 2022OACC 8-K 2022: current report for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences DEF 14A 2026OACC DEF 14A 2026: proxy statement for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences DEF 14A 2025OACC DEF 14A 2025: proxy statement for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences DEF 14A 2024OACC DEF 14A 2024: proxy statement for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences DEF 14A 2023OACC DEF 14A 2023: proxy statement for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences DEF 14A 2022OACC DEF 14A 2022: proxy statement for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences Form 4 2026OACC Form 4 2026: insider trading filing for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences Form 4 2025OACC Form 4 2025: insider trading filing for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences Form 4 2024OACC Form 4 2024: insider trading filing for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences Form 4 2023OACC Form 4 2023: insider trading filing for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences Form 4 2022OACC Form 4 2022: insider trading filing for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences S-1 2026OACC S-1 2026: registration statement for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences S-1 2025OACC S-1 2025: registration statement for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences S-1 2024OACC S-1 2024: registration statement for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences S-1 2023OACC S-1 2023: registration statement for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences S-1 2022OACC S-1 2022: registration statement for fiscal 2022
Oaktree Acquisition Corp. III Life Sciences 13F 2026OACC 13F 2026: institutional holdings for fiscal 2026
Oaktree Acquisition Corp. III Life Sciences 13F 2025OACC 13F 2025: institutional holdings for fiscal 2025
Oaktree Acquisition Corp. III Life Sciences 13F 2024OACC 13F 2024: institutional holdings for fiscal 2024
Oaktree Acquisition Corp. III Life Sciences 13F 2023OACC 13F 2023: institutional holdings for fiscal 2023
Oaktree Acquisition Corp. III Life Sciences 13F 2022OACC 13F 2022: institutional holdings for fiscal 2022

More companies